Results 41 to 50 of about 5,282,141 (310)
Clinical Insights Into Hypercalcemia of Malignancy in Childhood
Pediatric Blood &Cancer, EarlyView.ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley +1 more source
Redefining Cancer Research [PDF]
Science, 2009 Senator Ted Kennedy's recent death from malignant glioma, an incurable brain tumor, reminds us of the terrible toll that cancer takes on humanity. The United States alone experiences nearly 1.5 million new cases of cancer each year, resulting in more than 500,000 annual deaths, and about one-fourth of us will die in this way.
openaire +2 more sources
Humphrey Center News: Spring 1990 v. 5, no. 1 [PDF]
, 1990 Newsletter of the Hubert H.
Anthony, Richard P. +1 more
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine +14 more
wiley +1 more source
Cancer Surveillance Research [PDF]
Cancer Epidemiology, Biomarkers & Prevention, 2009 The journal Cancer Epidemiology, Biomarkers & Prevention ( CEBP ) has launched a new manuscript section entitled Cancer Surveillance Research (CSR). The CSR section will consist of original reports using cancer case and population data to examine, test, and develop hypotheses for cancer prevalence,
openaire +2 more sources
Humphrey Center News: Fall 1989 v. 4, no. 2 [PDF]
, 1989 Newsletter of the Hubert H.
Anthony, Richard P. +1 more
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács +8 more
wiley +1 more source
Humphrey Center News: Winter 1990 v. 5, no. 2 [PDF]
, 1990 Newsletter of the Hubert H.
Anthony, Richard P. +1 more
core
Experiences in supporting the structured collection of cancer nanotechnology data using caNanoLab
Beilstein Journal of Nanotechnology, 2015 The cancer Nanotechnology Laboratory (caNanoLab) data portal is an online nanomaterial database that allows users to submit and retrieve information on well-characterized nanomaterials, including composition, in vitro and in vivo experimental ...
Stephanie A. Morris +4 more
doaj +1 more source
Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism [PDF]
, 2018 C.L.-O. is supported by grants from the European Union (ERC-2016-ADG, DeAge); Ministerio de Economía y Competitividad (MINECO/FEDER: SAF2014-52413-R and SAF2017-87655-R); Instituto de Salud Carlos III (RTICC); Progeria Research Foundation (PRF2016-66 ...
Bárcena Fernández, Clea +11 more
core +3 more sources